By IDSE News Staff The FDA approved a new low-dose formulation of bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg tablets …
By IDSE News Staff The FDA approved a new low-dose formulation of bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg tablets …